Australian researchers found that a strain of the rotavirus previously thought unresponsive to sialidase, a standard protein therapy, actually recognized and attached to a type of sialic acid that is "not accessible" to the treatment. The researchers explored the interaction between the virus and its host cells with the aid of nuclear magnetic resonance spectroscopy, 3-D modeling and cell-based assays.

Full Story:

Related Summaries